MOG-antibody-associated disease is different from MS and NMOSD and should be classified as a distinct disease entity – Commentary
Author:
Affiliation:
1. Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Koriyama, Japan
Funder
ministry of education, culture, sports, science and technology
ministry of health, labour and welfare
Publisher
SAGE Publications
Subject
Neurology (clinical),Neurology
Link
http://journals.sagepub.com/doi/pdf/10.1177/1352458519895236
Reference10 articles.
1. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein
2. Neuromyelitis optica spectrum disorders: still evolving and broadening
3. MOG-antibody-associated disease is different from MS and NMOSD and should be considered as a distinct disease entity – Yes
4. MOG-antibody-associated disease is different from MS and NMO and should be considered as a distinct disease entity – No
5. Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Relapses and Serious Infections in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab: A Swedish Single-Center Study;Journal of Clinical Medicine;2024-01-08
2. The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab;Frontiers in Immunology;2023-08-15
3. Central nervous system complications in SARS-CoV-2-infected patients;Journal of Neurology;2023-08-13
4. A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD);Multiple Sclerosis and Related Disorders;2023-07
5. Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis;Frontiers in Immunology;2022-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3